Updated: Trump administration unfreezes, then refreezes, NIH funding to Columbia University
Morning agency email indicating resumption of hundreds of millions in grants is quickly undone
Related Articles
Intranasal Monoclonal Antibody Reduces Hay Fever and Asthma Symptoms in Mice
This could lead to the development of precision allergy treatments that are fast acting, needle free, and tailored to individual allergen sensitivities.
Protein Dynamics Predicted Rapidly with Generative AI Model, BioEmu
A newly developed generative AI model is helping researchers explore protein dynamics with increased speed.
Proteins with cognition-associated structural changes in a rat model of aging exhibit reduced refolding capacity
Up to 7% of rat hippocampal proteins undergo structural changes that associate with age-related decline in spatial learning.
Exclusive: NIH suspends dozens of pathogen studies over ‘gain-of-function’ concerns
Trump executive order leads to pauses on U.S.-funded research into TB, influenza, COVID-19, and other diseases, dismaying some scientists
Medical needles in the hands of AI: Advancing toward autonomous robotic navigation
AI guidance is enabling robots to perform medical needle-based procedures with greater safety and accuracy.
Rare Brain Disease ALSP Stalled by Microglia Replacement via Bone Marrow
Replacing defective microglia can halt ALSP—a fatal neurodegenerative disease—in mice and humans, offering hope for broader brain therapies.
Exclusive: NIH suspends dozens of pathogen studies over ‘gain-of-function’ concerns
Trump executive order leads to pauses on U.S.-funded research into TB, influenza, COVID-19, and other diseases, dismaying some scientists
Exclusive: NIH suspends dozens of pathogen studies over ‘gain-of-function’ concerns
Trump executive order leads to pauses on U.S.-funded research into TB, influenza, COVID-19, and other diseases, dismaying some scientists
Population health tech vendor Zyter|TruCare hires new CEO, unleashing new agentic AI coordination offering
Sundar Subramanian, a partner at PricewaterhouseCoopers (PwC) consulting affiliate Strategy&, has joined population health management company Zyter|TruCare as its newest CEO, Fierce Healthcare | AI…
An epigenetic editor to silence genes
A new class of editor has improved delivery, durability, tunability, and safety
